Stay updated on Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The footer revision label updates from v3.7.2 to v3.8.0. The page continues to show a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-02T16:27:34.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-26T16:42:00.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The site footer revision label changed from v3.7.1 to v3.7.2; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T21:52:40.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-13T04:21:11.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Access to the NCT03290079 study record is now blocked by a 403 Forbidden page, replacing the previous study content and navigation. The change means users cannot view the trial details on ClinicalTrials.gov until access is restored.
    Difference
    18%
    Check dated 2026-09-21T22:17:18.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    - The page now shows Revision: v3.6.6, replacing the previous v3.6.5, indicating a newer version of the study documentation.
    Difference
    0.1%
    Check dated 2026-08-31T17:23:24.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial page.